PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Götzfried, J. ; Smirnova, N.F. ; Morrone, C. ; Korkmaz, B.* ; Yildirim, A.Ö. ; Eickelberg, O. ; Jenne, D.

Preservation with alpha(1)-antitrypsin improves primary graft function of murine lung transplants.

J. Heart Lung Transpl. 37, 1021-1028 (2018)
Verlagsversion Postprint Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Vascular damage and primary graft dysfunction increase with prolonged preservation times of transplanted donor lungs. Hence, storage and conservation of donated lungs in protein-free, dextran-containing electrolyte solutions, like Perfadex, is limited to about 6 hours. We hypothesized that transplanted lungs are protected against neutrophil-mediated proteolytic damage by adding alpha(1)-antitrypsin (AAT), a highly abundant human plasma proteinase inhibitor, to Perfadex.METHODS: A realistic clinically oriented murine model of lung transplantation was used to simulate the ischemia-reperfusion process. Lung grafts were stored at 4 degrees C in Perfadex solution supplemented with AAT or an AAT mutant devoid of elastase-inhibiting activity for 18 hours. We examined wild-type and proteinase 3/neutrophil elastase (PR3/NE) double-deficient mice as graft recipients. Gas exchange function and infiltrating neutrophils of the transplanted lung, as well as protein content and neutrophil numbers in the bronchoalveolar lavage fluid, were determined.RESULTS: AAT as a supplement to Perfadex reduced the extent of primary graft dysfunction and early neutrophil responses after extended storage for 18 hours at 4 degrees C and 4-hour reperfusion in the recipients. Double-knockout recipients that lack elastase-like activities in neutrophils were also protected from early reperfusion injury, but not lung grafts that were perfused with a reactive center mutant of AAT devoid of elastase-inhibiting activity.CONCLUSIONS: PR3 and NE, the principal targets of AAT, are major triggers of post-ischemic reperfusion damage. Their effective inhibition in the graft and recipient is a promising strategy for organ usage after storage for >6 hours. (C) 2018 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.955
2.570
14
16
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Primary Graft Dysfunction ; Ischemia-reperfusion Injury ; Alpha-1-antitrypsin ; Elastase ; Proteinase 3 ; Animal Models ; Lung Transplantation; Ischemia-reperfusion Injury; Neutrophil Serine Proteases; Inflammatory Response; Cell Apoptosis; Alpha-1-antitrypsin; Aprotinin; Elastase; Proteinase-3; Dysfunction; Inhibition
Sprache englisch
Veröffentlichungsjahr 2018
HGF-Berichtsjahr 2018
ISSN (print) / ISBN 1053-2498
e-ISSN 1557-3117
Zeitschrift Journal of Heart and Lung Transplantation, The
Quellenangaben Band: 37, Heft: 8, Seiten: 1021-1028 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 360 Park Ave South, New York, Ny 10010-1710 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Lung Research
PSP-Element(e) G-501600-005
G-501600-006
G-505000-007
DOI 10.1016/j.healun.2018.03.015
WOS ID WOS:000441535600012
Scopus ID 85047079637
PubMed ID 29776812
Erfassungsdatum 2018-06-26
[➜Korrektur melden]